In this study, we validated seven potential biomarkers (AGR2, CCR2, CEBPD, CISH, CX3CR1, DEFB1, and FSTL1) associated with immune-related DN tubulointerstitial injury. The gene discussed is CISH; the disease is liver dysplastic nodule.